University of Pittsburgh researchers have identified several compounds capable of increasing cellular nicotinamide adenine dinucleotide (NAD) levels. Aging is linked to lower NAD levels, impacting cellular energy metabolism and production, in turn contributing to age-related decline in muscle and neuronal function. The use of orally available small molecules could be a novel approach to treating a variety of age-related conditions.
